ELUT
Price
$0.80
Change
-$0.04 (-4.76%)
Updated
Jan 15, 11:12 AM (EDT)
Capitalization
35.92M
48 days until earnings call
Intraday BUY SELL Signals
INBS
Price
$13.85
Change
-$1.75 (-11.22%)
Updated
Jan 15, 11:39 AM (EDT)
Capitalization
18.97M
Intraday BUY SELL Signals
Interact to see
Advertisement

ELUT vs INBS

Header iconELUT vs INBS Comparison
Open Charts ELUT vs INBSBanner chart's image
Elutia
Price$0.80
Change-$0.04 (-4.76%)
Volume$500
Capitalization35.92M
Intelligent Bio Solutions
Price$13.85
Change-$1.75 (-11.22%)
Volume$100
Capitalization18.97M
ELUT vs INBS Comparison Chart in %
ELUT
Daily Signal:
Gain/Loss:
INBS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ELUT vs. INBS commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a Hold and INBS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ELUT: $0.84 vs. INBS: $15.60)
Brand notoriety: ELUT and INBS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ELUT: 73% vs. INBS: 10%
Market capitalization -- ELUT: $35.92M vs. INBS: $18.97M
ELUT [@Medical/Nursing Services] is valued at $35.92M. INBS’s [@Medical/Nursing Services] market capitalization is $18.97M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 0 FA rating(s) are green whileINBS’s FA Score has 0 green FA rating(s).

  • ELUT’s FA Score: 0 green, 5 red.
  • INBS’s FA Score: 0 green, 5 red.
According to our system of comparison, INBS is a better buy in the long-term than ELUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 5 TA indicator(s) are bullish while INBS’s TA Score has 5 bullish TA indicator(s).

  • ELUT’s TA Score: 5 bullish, 5 bearish.
  • INBS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ELUT and INBS are a good buy in the short-term.

Price Growth

ELUT (@Medical/Nursing Services) experienced а +26.82% price change this week, while INBS (@Medical/Nursing Services) price change was +31.76% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.93%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +22.87%.

Reported Earning Dates

ELUT is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (+4.93% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELUT($35.9M) has a higher market cap than INBS($19M). INBS YTD gains are higher at: 63.694 vs. ELUT (21.842). INBS has higher annual earnings (EBITDA): -9.65M vs. ELUT (-21.52M). ELUT has more cash in the bank: 4.72M vs. INBS (1.02M). INBS has less debt than ELUT: INBS (1.95M) vs ELUT (29.1M). ELUT has higher revenues than INBS: ELUT (21.7M) vs INBS (3.29M).
ELUTINBSELUT / INBS
Capitalization35.9M19M189%
EBITDA-21.52M-9.65M223%
Gain YTD21.84263.69434%
P/E RatioN/A10.17-
Revenue21.7M3.29M659%
Total Cash4.72M1.02M463%
Total Debt29.1M1.95M1,491%
TECHNICAL ANALYSIS
Technical Analysis
ELUTINBS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ELUT
Daily Signal:
Gain/Loss:
INBS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUDI1.270.08
+6.72%
Huadi International Group Co Ltd
BBDC9.230.17
+1.88%
Barings BDC
CABA2.15N/A
N/A
Cabaletta Bio
ROP424.20-2.16
-0.51%
Roper Technologies
BDC117.89-0.95
-0.80%
Belden

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and RBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and RBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
-3.63%
RBOT - ELUT
31%
Poorly correlated
+1.81%
XAIR - ELUT
26%
Poorly correlated
-14.16%
STRRP - ELUT
23%
Poorly correlated
-1.08%
STRR - ELUT
23%
Poorly correlated
-0.27%
INBS - ELUT
23%
Poorly correlated
-6.42%
More

INBS and

Correlation & Price change

A.I.dvisor tells us that INBS and NVNO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INBS and NVNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBS
1D Price
Change %
INBS100%
-6.42%
NVNO - INBS
27%
Poorly correlated
+8.11%
ITGR - INBS
27%
Poorly correlated
+2.37%
WILLF - INBS
27%
Poorly correlated
N/A
LAB - INBS
26%
Poorly correlated
-2.45%
TWST - INBS
26%
Poorly correlated
-0.47%
More